Germany · Delayed Price · Currency is EUR Biofrontera AG Company Description
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products and medical products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.
The company offers Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma.
The company also provides RhodoLED XL lamp for the treatment of multiple interspersed lesions; and Belixos, a cosmetic product for irritated and sensitive skin.
In addition, the company focus on photodynamic therapy (PDT) for the treatment of actinic keratosis and keratinocyte skin cancers, including basal cell carcinoma.
The company has a license and supply agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.
| Country | Germany |
| Founded | 1997 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 74 |
Contact Details
Address: Hemmelrather Weg 201 Leverkusen, 51377 Germany | |
| Phone | 49 214 87632 0 |
| Website | biofrontera.com |
Stock Details
| Ticker Symbol | B8FK |
| Exchange | Deutsche Börse Xetra |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DE000A4BGGM7 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Pilar de la Huerta Martinez | Chief Financial Officer and Member of Executive Board |
| Alexander Richardson | Head of UK Sales Team |
| Dr. Matthias Naumann | Head of Sales and Marketing - Europe |
| Dr. Montserrat Foguet Ph.D. | Managing Director of Biofrontera UK Ltd. |